Jefferies Group’s Agios Pharmaceuticals AGIO Stock Holding History

Jefferies Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,400	Closed	-$835K	–	1503
2021 Q4	$835K	Buy	+25,400	New	+$1.02M	﹤0.01%	1054
2020 Q2	–	Sell	-23,700	Closed	-$841K	–	1258
2020 Q1	$841K	Buy	+23,700	New	+$1.1M	0.01%	1100
2017 Q1	–	Sell	-7,300	Closed	-$305K	–	2287
2016 Q4	$305K	Buy	+7,300	New	+$383K	﹤0.01%	1758
2016 Q3	–	Sell	-57,800	Closed	-$2.42M	–	2192
2016 Q2	$2.42M	Buy	57,800 +8,900	+18%	+$440K	0.01%	779
2016 Q1	$1.99M	Buy	48,900 +7,300	+18%	+$312K	0.01%	843
2015 Q4	$2.7M	Sell	41,600 -11,100	-21%	-$728K	0.02%	735
2015 Q3	$3.72M	Buy	+52,700	New	+$5.15M	0.02%	623
2015 Q1	–	Sell	-6,400	Closed	-$717K	–	2042
2014 Q4	$717K	Buy	+6,400	New	+$571K	﹤0.01%	1116

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group's AGIO Position: Q3 2022 in Review

Jefferies Group sold out of Agios Pharmaceuticals (AGIO) in Q3 2022, closing a stake of 17,010 shares — an estimated $377K sold.

Jefferies Group first reported a position in AGIO in Q2 2015 and held it in 12 quarters. The position peaked at $1.75M in Q3 2019. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

Jefferies Group reported no remaining Agios Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 17,010 Agios Pharmaceuticals shares in Q3 2022, an estimated $377K.
Jefferies Group first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 12 quarters.
Jefferies Group's Agios Pharmaceuticals position peaked at $1.75M in Q3 2019.
168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.